Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study (vol 205, pg 135, 2014)

被引:0
|
作者
不详
机构
关键词
D O I
10.1192/bjp.205.5.412a
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:412 / 412
页数:1
相关论文
共 50 条
  • [41] Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study
    Daniel Schöttle
    Wolfgang Janetzky
    Daniel Luedecke
    Elmar Beck
    Christoph U. Correll
    Klaus Wiedemann
    BMC Psychiatry, 18
  • [42] Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial
    Papi, Alberto
    Marku, Brunilda
    Scichilone, Nicola
    Maestrelli, Piero
    Paggiaro, Pierluigi
    Saetta, Marina
    Nava, Stefano
    Folletti, Ilenia
    Bertorelli, Giuseppina
    Bertacco, Stefano
    Contoli, Marco
    Plebani, Mario
    Barbaro, Maria Pia Foschino
    Spanevello, Antonio
    Aliani, Maria
    Pannacci, Marco
    Morelli, Paolo
    Beghe, Bianca
    Fabbri, Leonardo M.
    LANCET RESPIRATORY MEDICINE, 2015, 3 (02): : 109 - 119
  • [43] Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study (vol 7, pg 75, 2020)
    Szerman, Nestor
    Basurte-Villamor, Ignacio
    Vega, Pablo
    Martinez-Raga, Jose
    Parro-Torres, Carlos
    Cambra Almerge, Julia
    Grau-Lopez, Lara
    De Matteis, Mario
    Arias, Francisco
    DRUGS-REAL WORLD OUTCOMES, 2020, 7 (01) : 85 - 85
  • [44] Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): A Randomized Double-Blind Non-Inferiority Trial
    Lee, Yong-Seok
    Bae, Hee-Joon
    Kang, Dong-Wha
    Lee, Seung-Hoon
    Yu, Kyungho
    Park, Jong-Moo
    Cho, Yong-Jin
    Hong, Keun-Sik
    Kim, Dong-Eog
    Kwon, Sun Uck
    Lee, Kyung Bok
    Rha, Joung-Ho
    Koo, Jaseong
    Han, Moon-Gu
    Lee, Soo Joo
    Lee, Ju-Hun
    Jung, Sang Wook
    Lee, Byung-Chul
    Kim, Jong S.
    CEREBROVASCULAR DISEASES, 2011, 32 (01) : 65 - 71
  • [45] Micafungin versus caspofungin in patients with invasive candidiasis or candidaemia: a Phase III, randomised, double-blind, parallel group, non-inferiority study
    Dupont, B.
    De Waele, J.
    Betts, R.
    Rotstein, C.
    Nucci, M.
    Arnold, L.
    Kovanda, L.
    Wu, C.
    Buell, D.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S28 - S28
  • [46] Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial
    Ljostad, Unn
    Skogvoll, Eirik
    Eikeland, Randi
    Midgard, Rune
    Skarpaas, Tone
    Berg, Ase
    Mygland, Ase
    LANCET NEUROLOGY, 2008, 7 (08): : 690 - 695
  • [47] Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial (vol 370 pg 949, 2007)
    Eriksson, B., I
    Dahl, O. E.
    Rosencher, N.
    LANCET, 2007, 370 (9604): : 2004 - 2004
  • [48] Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial
    Shinohara, Yukito
    Katayama, Yasuo
    Uchiyama, Shinichiro
    Yamaguchi, Takenori
    Handa, Shunnosuke
    Matsuoka, Kempei
    Ohashi, Yasuo
    Tanahashi, Norio
    Yamamoto, Hiroko
    Genka, Chokoh
    Kitagawa, Yasuhisa
    Kusuoka, Hideo
    Nishimaru, Katsuya
    Tsushima, Motoo
    Koretsune, Yukihiro
    Sawada, Tohru
    Hamada, Chikuma
    LANCET NEUROLOGY, 2010, 9 (10): : 959 - 968
  • [49] Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial
    Kenemans, Peter
    Bundred, Nigel J.
    Foidart, Jean-Michel
    Kubista, Ernst
    von Schoultz, Bo
    Sismondi, Piero
    Vassilopoulou-Sellin, Rena
    Yip, Cheng Har
    Egberts, Jon
    Mol-Arts, Mirjam
    Mulder, Roel
    van Os, Steve
    Beckmann, Matthias W.
    LANCET ONCOLOGY, 2009, 10 (02): : 135 - 146
  • [50] Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
    Vickers, Richard J.
    Tillotson, Glenn S.
    Nathan, Richard
    Hazan, Sabine
    Pullman, John
    Lucasti, Christopher
    Deck, Kenneth
    Yacyshyn, Bruce
    Maliakkal, Benedict
    Pesant, Yves
    Tejura, Bina
    Roblin, David
    Gerding, Dale N.
    Wilcox, Mark H.
    LANCET INFECTIOUS DISEASES, 2017, 17 (07): : 735 - 744